Literature DB >> 26489764

The role of the Src Homology-2 domain containing protein B (SHB) in β cells.

Michael Welsh1, Maria Jamalpour2, Guangxiang Zang2, Björn Åkerblom2.   

Abstract

This review will describe the SH2-domain signaling protein Src Homology-2 domain containing protein B (SHB) and its role in various physiological processes relating in particular to glucose homeostasis and β cell function. SHB operates downstream of several tyrosine kinase receptors and assembles signaling complexes in response to receptor activation by interacting with other signaling proteins via its other domains (proline-rich, phosphotyrosine-binding and tyrosine-phosphorylation sites). The subsequent responses are context-dependent. Absence of Shb in mice has been found to exert effects on hematopoiesis, angiogenesis and glucose metabolism. Specifically, first-phase insulin secretion in response to glucose was impaired and this effect was related to altered characteristics of focal adhesion kinase activation modulating signaling through Akt, ERK, β catenin and cAMP. It is believed that SHB plays a role in integrating adaptive responses to various stimuli by simultaneously modulating cellular responses in different cell-types, thus playing a role in maintaining physiological homeostasis.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  immune system; insulin secretion; islet cells; signal transduction; vascular

Mesh:

Substances:

Year:  2015        PMID: 26489764     DOI: 10.1530/JME-15-0228

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  8 in total

1.  In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.

Authors:  Wan-Shan Yang; Mel Campbell; Hsing-Jien Kung; Pei-Ching Chang
Journal:  J Vis Exp       Date:  2018-01-29       Impact factor: 1.355

2.  SmShb, the SH2-Containing Adaptor Protein B of Schistosoma mansoni Regulates Venus Kinase Receptor Signaling Pathways.

Authors:  Marion Morel; Mathieu Vanderstraete; Katia Cailliau; Steffen Hahnel; Christoph G Grevelding; Colette Dissous
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

3.  Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas.

Authors:  Xiujuan Li; Kailash Singh; Zhengkang Luo; Mariela Mejia-Cordova; Maria Jamalpour; Björn Lindahl; Ganlin Zhang; Stellan Sandler; Michael Welsh
Journal:  Oncotarget       Date:  2018-04-10

4.  The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors.

Authors:  Qi He; Xiujuan Li; Kailash Singh; Zhengkang Luo; Mariela Meija-Cordova; Maria Jamalpour; Björn Lindahl; Vitezslav Kriz; Reetta Vuolteenaho; Maria Ulvmar; Michael Welsh
Journal:  Sci Rep       Date:  2019-05-17       Impact factor: 4.379

5.  Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB.

Authors:  Ilkka Pietilä; Djenolan Van Mourik; Andreas Tamelander; Vitezslav Kriz; Lena Claesson-Welsh; Anders Tengholm; Michael Welsh
Journal:  Cells       Date:  2019-12-15       Impact factor: 6.600

6.  Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in Shb-Deficient Endothelial Cells Increases Tumor Lung Metastasis.

Authors:  Qi He; Maria Jamalpour; Eric Bergquist; Robin L Anderson; Karin Gustafsson; Michael Welsh
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

7.  Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.

Authors:  Karolin Ebert; Ivonne Haffner; Gwen Zwingenberger; Simone Keller; Elba Raimúndez; Robert Geffers; Ralph Wirtz; Elena Barbaria; Vanessa Hollerieth; Rouven Arnold; Axel Walch; Jan Hasenauer; Dieter Maier; Florian Lordick; Birgit Luber
Journal:  BMC Cancer       Date:  2022-03-09       Impact factor: 4.430

8.  Evaluation and validation of commercial antibodies for the detection of Shb.

Authors:  Güliz Vanli; Alvaro Cuesta-Marban; Christian Widmann
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.